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Modulation of Synaptic Efficacy
and Synaptic Depression by Glial Cells
at the Frog Neuromuscular Junction
activities, in part in response to neuronal activity (Neder-
gaard, 1994; Parpura et al., 1994, 1995; Pasti et al., 1997;
Pfrieger and Barres, 1997; Bezzi et al., 1998). However,
it remains unclear whether glial cells are directly involved
in the regulation of synaptic activity and how this modu-
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lation could be achieved.Canada
In the peripheral nervous system, similar to the glial
cells in the central nervous system, perisynaptic Schwann
cells (PSCs), which cover the neuromuscular junctionSummary
(nmj), also possess ion channels (Robitaille et al., 1996)
and receptors for various transmitters and react to theThe ability of perisynaptic glial cells to modulate trans-
release of endogenous neurotransmitters (Jahromi et
mitter release and synaptic depression was studied
al., 1992; Reist and Smith, 1992; Georgiou et al., 1994;
at the frog neuromuscular junction (nmj). Injection of
Robitaille, 1995). The frog nmj provides a simple system
GTPgS in perisynaptic Schwann cells (PSCs), glial cells
in which the relationship between the glial, pre-, and
at this synapse, induced a reduction in the amplitude
postsynaptic elements is well established, and the inter-
of nerve-evoked synaptic responses but had no effect actions between synapse and glial cells can be studied
on the frequency, the amplitude, or the duration of at the level of a single synapse. Taking advantage of
the miniature endplate currents (MEPCs). Also, paired the preserved and intact anatomical relationship be-
pulse facilitation was not affected. The reduction in tween glial cells and the pre- and postsynaptic elements,
transmitter release was mediated by pertussis toxin± the hypothesis that glial cells can modulate synaptic
(PTX) sensitive and insensitive G proteins. Blockade efficacy in situ was studied at the amphibian nmj. Also,
of G proteins in PSCs with GDPbS reduced synaptic since high frequency stimulation activates PSCs, we
depression induced by high frequency trains of stimuli, tested the possibility that depression caused by high
whereas activation of G proteins occluded it. Hence, frequency stimulations was, in part, due to the modula-
the activation by endogenous neurotransmitters of G tion of PSCs.
proteins in PSCs induced a profound depression in The major mechanism by which PSCs react to nerve
neurotransmitter release. terminal activity is the activation of muscarinic, pu-
rinergic, or even peptidergic receptors, the majority of
Introduction which are coupled to pertussis toxin± (PTX) sensitive or
insensitive G proteins (Georgiou et al., 1994; Robitaille,
The two major cellular elements in the nervous system 1995; Robitaille et al., 1997; Bourque and Robitaille,
are the neurons and the glial cells. The importance and 1998). Hence, it is quite likely that modulatory actions
critical role of neurons in the transfer of information in of PSCs on synaptic activity may also be governed by
the nervous system is now well established. Although G protein±activated cascades of second messengers.
the involvement of glial cells in the regulation of the To test whether PSCs could modulate synaptic activity,
extracellular environment of neurons by buffering ions, nonhydrolyzable GTP analogs were used to modulate
removing metabolic wastes, and capturing neurotrans- G proteins of PSCs. A technique was developed to spe-
mitters is well accepted (Smith, 1992; Vernadakis, 1996), cifically introduce drugs into PSCs without damaging
the potential role of glial cells in the processing of neu- them or affecting the nerve terminal. Using this ap-
ronal information remains unclear and is still ill defined. proach, it is shown that the potentiation of G proteins
Interestingly, glial cells possess many characteristics in PSCs causes a reduction in transmitter release and
that would allow them to play a role in regulating neu- that the blockade of G protein activation greatly reduced
ronal activity as well as synaptic transmission, the basis the amount of synaptic depression generated by high
of the transfer of information in the nervous system. Glial frequency stimulations. It is concluded that perisynaptic
glial cells modulate the activity of chemical synapsescells possess ion channels and receptors for various
and regulate the level of synaptic depression produced.neurotransmitters (Kimelberg, 1995), and they tightly
surround synapses in the central and peripheral nervous
Resultssystems (Smith, 1992). Owing to the presence of ion
channels and receptors in their processes, glial cells
Injection Procedures Do Not Affect Transmitterdetect and react to neuronal and synaptic activities by
Release and PSC Activityan increase in intracellular Ca21 and by the regulation
To determine whether PSCs regulate synaptic activity,of the expression of certain genes (Cornell-Bell et al.,
a method was developed to inject drugs directly into1990; Dani et al., 1992; Finkbeiner, 1993; Kriegler and
the PSCs to specifically alter their metabolism withoutChiu, 1993; Chiu and Kriegler, 1994; Porter and McCar-
affecting other synaptic components. It was possiblethy, 1995; Vernadakis, 1996). More importantly, recent
to ionophoretically inject the fluorescent Ca21 indicatorevidence indicates that glial cells can regulate neuronal
Ca21-green-1 in PSCs using sharp microelectrodes (Fig-
ures 1A and 1B). Endplate currents were recorded fo-
cally at the area of the nmj covered by the injected* E-mail: robitair@ere.umontreal.ca.
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Figure 1. Injection Procedures Do Not Affect
Transmitter Release and PSC Activity
(A) Transmitted light image of a frog nmj in
which a cell body of a PSC is visible (arrow).
A muscle fiber was first impaled by a micro-
electrode (EMF), and another microelectrode
was positioned near a nerve terminal branch
for focal recordings of transmitter release
(EFOC). A PSC covering the branch recorded
by the focal electrode was then impaled by
a sharp microelectrode (EPSC) that was used
for injection of the various drugs.
(B) A fluorescent image of the PSC shown in
(A) after ionophoretic injection of Ca21 green-1.
(C) EPC amplitude recorded by the focal elec-
trode before, during, and after injection of
Ca21 green-1 into a PSC (different cell than
in [A] and [B]). Only the amplitude of the first
EPC is illustrated. A pair of EPCs before and
after injection of Ca21 green-1 in PSCs is illus-
trated in the inset.
(D) Relative changes of intracellular Ca21 in a
PSC injected with Ca21 green-1 before, dur-
ing, and after repetitive motor nerve stimula-
tion (50 Hz, 30 s) (different cell than in [A], [B],
and [C]).
PSC to monitor the possible effects of the injection on endplate potentials [EPPs] of z1 mV) or high (m-cono-
toxin GIIIA, EPPs of z40±50 mV).synaptic activity. No effect on endplate current (EPC)
amplitude was ever observed when the criteria for a We tested for two possible artifacts. First, the reduc-
tion in EPC amplitude may have been due to the spillovergood PSC penetration were followed (see Experimental
Procedures) (Figure 1C). Also, neither the presynaptic of the drug onto the nerve terminals during the injection.
Bath application of 1 mM GTPgS (a concentration of atnerve action potential (PNAP) nor the kinetics of sponta-
neous miniature EPCs (MEPC) were affected (data not least twice the dilution of the drug extruded from the
electrode by local application; Robitaille et al., 1997;shown). This suggested that the injection per se did not
perturb the activity of the presynaptic nerve terminal. Bourque and Robitaille, 1998) (Figure 2C) and ionopho-
retic, extracellular application near the nerve terminalAlso, the injection protocol did not interfere with the
normal activity of the injected PSC, since it retained its (10 mM in the electrode) had no effect on transmitter
release. Second, a possible mechanical displacementability to react to neurotransmitters released by repeti-
tive stimulations of the motor nerve as shown by large of the nerve terminal might have occurred during the
penetration and injection of the PSC, thus reducing theCa21 responses (Figure 1D). This test was critical, since
the induction of the Ca21 elevation in the PSCs is con- size of the focally recorded EPCs. Indeed, the amplitude
of the EPC recorded by the focal electrode is directlytrolled by a complex network of second messengers
and requires the activation of multiple types of receptors related to the distance between the recording electrode
and the nerve terminal (Bennett and Lavidis, 1989). How-and G proteins (Robitaille, 1995; Robitaille et al., 1997;
Bourque and Robitaille, 1998). This observation sug- ever, as shown in Figure 2D, the amplitude and shape
of the PNAP were unchanged following the injection ofgests that PSCs functioned normally after the injection
of the Ca21 indicator. Therefore, these control experi- GTPgS in the PSC, arguing that the recording electrode
remained at the same location. This criterion was usedments indicate that the protocol can be used to test
the involvement of PSCs in the modulation of synaptic for all experiments. It is possible to conclude that the
changes in EPC amplitude cannot be explained by suchtransmission.
mechanisms and, hence, are likely due to the activation
of G proteins by GTPgS in PSCs.Activation of G Proteins in PSCs Induces
Synaptic Depression
The ability of PSCs to modulate synaptic transmission Presynaptic Modulation by PSCs
The implication of pre- or postsynaptic mechanisms inwas tested by injecting GTPgS, the nonhydrolyzable
analog of GTP (Yoshino and Yabu, 1995; Yu et al., 1995; the reduction in EPC amplitude by GTPgS injection in
PSCs was examined by measuring the changes in theHoffenberg et al., 1996). Ionophoretic injection of GTPgS
(10 mM in the electrode) produced a reduction of frequency, amplitude, and duration of MEPC. The ampli-
tude and duration of the spontaneous events should57.4% 6 4.8% (n 5 9) of EPC amplitude 30 min after
the injection (Figures 2A and 2B). Similar results were be affected if the reduction in EPC amplitude involved
postsynaptic mechanisms. In contrast, changes in theobtained when muscle contractions were blocked by
d-tubocurarine chloride or m-conotoxin GIIIA, indicating frequency of the spontaneous events would reflect pre-
synaptic effects. Even though the amplitude of thethat the modulation of PSC G proteins on synaptic activ-
ity was similar whether the level of electrical activity evoked EPC was reduced, injection of GTPgS neither
changed the frequency nor the amplitude of the MEPCsof the muscle fiber was low (d-tubocurarine chloride,
Modulation of Synaptic Activity by Glial Cells
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Figure 2. Injection of GTPgS in PSCs De-
presses Synaptic Transmission
(A) EPC amplitude recorded focally from a
nerve terminal branch and evoked by a single
stimulus at 0.2 Hz before, during, and after
injection of GTPgS in the PSC covering the
same terminal branch. The injection of GTPgS
into the PSC produced a reduction in the am-
plitude of EPC.
(B) Average of four EPCs recorded before
(control) and 20 min after the injection of
GTPgS in the PSC (GTPgS).
(C) Normalized EPP amplitude relative to con-
trol, before, and during bath application of
GTPgS (1 mM). Inset illustrates an EPP in con-
trol and 30 min after the application of GTPgS.
Bath application of GTPgS had no effect on
EPP amplitude.
(D) PNAP (arrows) recorded before (control)
and 30 min after the injection of GTPgS in
the PSC. Note that neither the shape nor the
amplitude of the PNAP were affected.
(Figures 3A and 3B). In control, MEPC amplitude was would be occluded if it were mediated solely by PTX-
sensitive G proteins. However, a lack of effect would298 6 52 mV and the frequency was 0.11 6 0.03 Hz in
comparison to 293 6 47 mV and 0.11 6 0.03 Hz after reflect the involvement of PTX-insensitive G proteins.
GTPgS injection in PTX-treated PSCs significantly re-GTPgS injection in PSCs (n 5 4, paired Student's t test,
p . 0.05). There was no significant change in MEPC duced EPC amplitude by 21% 6 5.4% after 30±40 min
(n 5 5, Student's t test, p , 0.05; Figure 5A), indicatingamplitude or frequency in all experiments. Also, as
shown in Figure 3C, the duration and rise time of the that PTX-insensitive G proteins were involved.
However, the effects of GTPgS on PTX-treated prepa-MEPCs did not change following GTPgS injection in
PSCs. Hence, the modulation induced by G protein acti- rations was not as important as the one observed on
untreated preparation. Indeed, the dotted line in Figurevation in PSCs was presynaptic, and the reduction in
EPC amplitude was due to a reduction in the amount 5A illustrates the average reduction in EPC amplitude
observed in control preparations, thus the level of reduc-of transmitter released.
tion that should have been observed. When compared,
the percentage reduction of EPC amplitude by GTPgSModulation by PSCs Does Not Affect Paired
Pulse Facilitation injection in PTX-treated preparations was significantly
smaller than on the untreated preparations (Student's tKnowing that the modulation of PSCs was presynaptic
in origin, the effect of PSCs on the production of paired test, p , 0.05; Figure 5B). This suggests that PTX-sensi-
tive G proteins were also involved in the modulation ofpulse facilitation, a well known presynaptic phenome-
non (Charlton et al., 1982; Zucker, 1989), was next inves- synaptic activity.
tigated. In addition, the study of paired pulse facilitation
may also help to further characterize the presynaptic
PSCs Do Not Modulate Synapticloci on which the modulatory actions of PSCs may take
Transmission Tonicallyplace. Facilitation was defined as the ratio between the
To determine whether PSCs modulate transmitter re-amplitude of a second EPC (EPC1) evoked by a stimulus
lease on a tonic basis, G proteins were blocked by in-at an interval of 10 ms after the first EPC (EPC0). As
jecting the nonhydrolyzable analog of GDP, GDPbSshown in Figure 4A, while the release of neurotransmit-
(Hess et al., 1993; Ma et al., 1994; Salter and Hicks, 1995;ters was reduced, paired pulse facilitation was not af-
Reich et al., 1997). In these conditions, the blockade offected by the injection of GTPgS in PSCs (0.7 6 0.05 in
G proteins should increase the amplitude of synapticcontrol, 0.72 6 0.08 after GTPgS injection; n 5 6, paired
responses if PSCs reduced the release of neurotransmit-Student's t test, p 5 0.49). In fact, once the amplitude
ters tonically.of EPC0 was scaled to match the amplitude of the first
However, the injection of GDPbS had no effect onEPC of control, EPC1 matched perfectly the one from
transmitter release (Figure 6A). Indeed, EPC amplitudethe control frame, indicating that the level of facilitation
was 326.8 6 46.8 mV in control in comparison to 315.0 6was unchanged after GTPgS injection (Figure 4B).
48.2 mV after GDPbS injection in PSCs, a reduction of
4% of control value (n 5 5, paired Student's t test, p .Involvement of PTX-Sensitive
0.05). Similarly, homosynaptic facilitation was not af-and Insensitive G Proteins
fected (Figure 6B), as it was 1.08 6 0.15 in control andPreparations were treated with PTX (2 mg/ml overnight)
1.11 6 0.16 after GDPbS injection (n 5 5, paired Stu-to determine which type of G protein was activated fol-
dent's t test, p 5 0.6). The lack of effect of GDPbS islowing the injection of GTPgS in PSCs. In these condi-
tions, the modulation of transmitter release by PSCs not likely due to bad injections, because the coinjected
Neuron
850
Figure 4. Injection of GTPgS in PSCs Does Affect Paired Pulse Facil-
itation
(A) Paired pulse facilitation (F 5 (EPC12EPC0)/EPC0) before, during,
and after injection of GTPgS in the PSC.
(B) An average of four EPCs before (control) and 20 min after the
injection of GTPgS in the PSC (GTPgS). The amplitude of the first
EPC of the pair recorded after the injection of GTPgS has been
scaled by 2.13 to match the amplitude of the control EPC. Note
Figure 3. Injection of GTPgS in PSCs Reduces Transmitter Release that the amplitude of the second EPC after injection of GTPgS was
(A) Histograms of MEPC frequency and amplitude from the experi- not different from control.
ment illustrated in Figure 2. Filled bars represent control values and
open bars the values 20 min after the injection of GTPgS in the PSC.
Injection of GTPgS had no effect on the frequency or the amplitude
Depression of transmitter release was measured in theof the MEPC.
same nmjs before and after blockade of G proteins in(B) Randomly selected samples of MEPCs recorded before (control)
PSCs following injection of GDPbS.and 20 min after injection of GTPgS in the PSC (GTPgS).
(C) Average of ten randomly selected MEPCs from control and 20 As shown in Figure 7A, the amplitude of EPCs fell by
min after the injection of GTPgS. Note that neither the shape nor 58% 6 4.2% (n 5 5) during a train of stimuli at 10 Hz
the amplitude of MEPC were affected. for 80 s. Similar synaptic depression could be obtained
repetitively on the same preparation following recovery
of a previous train of stimuli (n 5 3). However, synapticCa21 indicator was seen in PSCs (inset, Figure 6A). More-
over, adenosine and Substance P, which normally in- depression was only 27.6% 6 3.9% (n 5 5) following
GDPbS injection in PSCs of the same nmjs previouslyduce Ca21 responses in PSCs by activating PTX-sensi-
tive G proteins (Robitaille, 1995; Robitaille et al., 1997; recorded (Figure 7B). This was significantly different
from control (paired Student's t test, p , 0.001; FigureBourque and Robitaille, 1998), failed to do so in PSCs
injected with GDPbS (data not shown), confirming the 7C). The reduction in synaptic depression was not due
to a direct effect of GDPbS that could have leaked outblockade of G proteins by the GTP analog.
of the PSCs or from the electrode, since bath application
of GDPbS (1 mM) had no effect on synaptic depressionHigh Frequency Synaptic Depression
Is Modulated by PSCs induced by nerve stimulation (48% 6 8% in control,
45% 6 7% in GDPbS; n 5 3).Since the activation of G proteins in PSCs induced a
reduction in transmitter release, the involvement of These results may suggest that the depression in-
duced by activating PSC G proteins involved mecha-PSCs in synaptic depression was investigated. This was
tested by stimulating the motor nerve with high fre- nisms similar to those causing depression during high
frequency stimulation of the motor nerve. If this were thequency trains of stimuli (10 Hz), a protocol known to
induce synaptic depression. The level of depression was case, depression induced by high frequency stimulation
should be occluded by the depression induced by in-determined by measuring the amplitude of the last 50
EPCs of the 10 Hz train of stimuli and was expressed jecting GTPgS in PSCs. To test this possibility, synaptic
depression induced by high frequency stimulation of theas the relative reduction in EPC amplitude in comparison
to EPC amplitude before the high frequency stimulation. motor nerve was measured before and after injection
Modulation of Synaptic Activity by Glial Cells
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Figure 5. Involvement of PTX-Sensitive and Insensitive G Proteins
(A) Muscles were incubated overnight in PTX (2 mg/ml). EPC ampli-
tude recorded focally from a nerve terminal branch and evoked by
single stimulus at 0.2 Hz before, during, and after injection of GTPgS
in the PSC covering the recorded terminal branch. Note that the
injection of GTPgS produced a significant reduction of 25% in EPC
Figure 6. PSCs Do Not Modulate Transmitter Release Tonicallyamplitude. The dashed line represents the expected level of reduc-
tion (57.4%) as determined from the experiments in the absence (A) EPC amplitude recorded focally and evoked by a single stimulus
of PTX. at 0.2 Hz before, during, and after injection of GDPbS in a PSC. The
(B) Bar graphs of the percentage of reduction of EPC amplitude inset illustrates the PSC injected with GDPbS (10 mM) and Ca21
induced by the injection of GTPgS in untreated (closed symbol) and green-1. Note that the injection of GDPbS had no effect on EPC
PTX-treated PSCs (open symbol). The value for the GTPgS effect amplitude.
is the same as in Figure 2. Note that the reduction in PTX-treated (B) Paired pulse facilitation (F 5 (EPC1-EPC0)/EPC0) before and after
cells is significantly smaller than in nontreated PSCs (asterisk means injection of GDPbS in the PSC. Homosynaptic facilitation was not
p , 0.05 with a Student's t test). affected by the injection of GDPbS in PSCs.
of GTPgS in PSCs. Nerve-induced synaptic depression Specific Modulation of PSCs
was significantly reduced after the induction of depres- The protocol used in these experiments allowed us to
sion by GTPgS, when it was 40% 6 2% in control (Fig- specifically modulate the perisynaptic glial cells without
ures 7D and 7F) and only 11% 6 4% after GTPgS injec- affecting the normal activity of the glia and the associ-
tion in PSCs (n 5 4, paired Student's t test, p 5 0.01; ated synapse as indicated by the lack of effect on PSC
Figures 7E and 7F) Hence, nerve-evoked synaptic de- activity or on transmitter release during injection of Ca21
pression was occluded by the depression induced by indicator. Also, the effects of GTPgS on transmitter re-
PSC G protein activation. In some cases, after GTPgS lease are not likely due to the drug that may have leaked
injection, high frequency stimulations revealed a pro- out of the PSCs or simply leaked out of the electrode
pensity for transmitter release to be potentiated rather during the injection procedures, since direct bath appli-
than depressed (Figure 7E). These results indicate that cation of GTPgS had no effect on transmitter release.
high frequency synaptic depression requires the activa- Moreover, it is unlikely that the results can be attrib-
tion of PSC G proteins in order to fully develop. uted to a direct injection of GTPgS into the presynaptic
nerve terminal for two main reasons. First, nerve termi-
nals are extremely sensitive to mechanical disturbance
Discussion and to poking with sharp electrodes, which results in a
sudden increase in spontaneous events. This implies
In this study, direct evidence is presented that peri- that the nmj would have been excluded from the study,
synaptic glial cells modulate synaptic activity in re- since this sudden increase of miniature endplate poten-
sponse to synaptic activity itself, indicating that glial tial (MEPP) frequency is one of the exclusion criteria (see
cells are involved in a synapse±glia±synapse feedback Experimental Procedures). Second, although unlikely, if
the penetration had been performed without any sideloop interaction.
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Figure 7. PSCs Modulate Endogenous High
Frequency Depression
(A) EPC amplitude expressed as a percentage
of control value before, during, and after a
train of stimuli (10 Hz, 80 s) recorded before
the injection of the PSC with GDPbS. EPCs
were evoked at a frequency of 0.2 Hz before
and after the train of stimuli.
(B) EPC amplitude expressed as a percent-
age of control value from the same nmj as in
(A) before, during, and after a train of stimuli
(10 Hz, 80 s) applied 25 min following GDPbS
injection in the PSC covering the nerve termi-
nal branch recorded by the focal electrode.
EPCs were evoked at a frequency of 0.2 Hz
before and after the train of stimuli.
(C) Average depression in control (closed
symbol) and following GDPbS injection in
PSCs (open symbol) (n 5 5). Note that the
amount of synaptic depression was signifi-
cantly reduced (asterisk means p , 0.05, Stu-
dent's t test).
(D) EPC amplitude expressed as a percent-
age of control value before, during, and after
a train of stimuli (10 Hz, 80 s) recorded before
the injection of the PSC with GTPgS. EPCs
were evoked at a frequency of 0.2 Hz before
and after the train of stimuli.
(E) EPC amplitude expressed as a percentage
of control value from the same nmj as in (D)
before, during, and after a train of stimuli (10
Hz, 80 s) applied 35 min following GTPgS in-
jection in the PSC covering the nerve terminal
branch recorded by the focal electrode.
EPCs were evoked at a frequency of 0.2 Hz
before and after the train of stimuli.
(F) Average depression in control (closed
symbol) and following GTPgS injection (open
symbol) in PSCs (n 5 4). Note that the amount
of synaptic depression was significantly re-
duced (asterisk means p 5 0.02, paired Stu-
dent's t test).
effects, the fluorescent indicator always present in the cascades reduced only evoked transmitter release and
not the frequency of spontaneous events and did notinjection electrode should have diffused into a major
portion of the nerve terminal and not only into the area affect the level of paired pulse facilitation.
These observations are in line with results obtainedcovered by the injected PSC. Indeed, David et al. (1997)
showed that the injection of a Ca21 indicator by the from cocultures of neurons and astrocytes that showed
that glial cells can modulate neuronal activity (Neder-perinodal recording technique diffused throughout the
entire lizard presynaptic nerve terminal. This was never gaard, 1994; Parpura et al., 1994) and synaptic efficacy
during synapse formation (Pfrieger and Barres, 1997).observed in the present experiments. Therefore, these
observations strongly suggest that it was the activation However, an important difference exists between PSCs
at the nmj and astrocytes in culture and in hippocampalof PSC G proteins by GTPgS that caused the reduction
in transmitter release rather than a direct action on the slices. Indeed, astrocytes enhanced neuronal excitabil-
ity by, for example, increasing the membrane potentialpresynaptic terminal.
(Parpura et al., 1994) or by enhancing synaptic efficacy
during synapse formation (Pfrieger and Barres, 1997),Glial Cells Modulate Neuronal Activity
and Synaptic Efficacy whereas PSC activity reduced synaptic efficacy and
strength. This difference may originate from two mainThe results obtained in the present study provide direct
evidence that perisynaptic glial cells in situ modulate factors. First, glial cells in culture may function differ-
ently than in a normal, in situ or in vivo environment;synaptic activity and reduce the efficacy of the synapse,
owing to a reduction in the amount of transmitter re- and second, glial cells may perform different regulatory
actions adapted to the neuronal environment and ad-leased. The modulation of synaptic efficacy by PSCs
appears targeted toward the synchronization mecha- justed to the level of neuronal activity and to the strength
of the synapses. For instance, frog nmj is a strong syn-nisms that are necessary for the production of quantal
release and not on the basic mechanisms required for apse with a very high safety factor, where a reduction in
synaptic activity may be important to minimize synapticvesicular fusion. Indeed, the activation of PSC G protein
Modulation of Synaptic Activity by Glial Cells
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fatigue and the rundown of neurotransmitters. Interest- inability to induce any Ca21 responses in the presence
of GDPbS indicates that the vast majority of G proteinsingly, Newman and Zahs (1998) showed that the activa-
tion of glial cells in the retina generally inhibited light- were inactivated. Therefore, it is concluded that part of
synaptic depression was caused by the activation ofinduced spiking activity in ganglion cells.
PSCs following the release of neurotransmitters, and the
remainder probably originated from the nerve terminalWhich Endogenous Neurotransmitters
itself.May Be Involved?
It is believed that the depression induced by repetitive,There are several neurotransmitters released by the
high frequency stimulations may be due to the depletionnerve terminal that are possible candidates for activat-
of the readily releasable pool of neurotransmitters. Thising PSCs. Indeed, PTX-sensitive and insensitive G pro-
would be consistent with the observation that GTPgSteins are involved in the regulation of synaptic efficacy
injections in PSCs only affected nerve-evoked transmit-by PSCs as suggested by the observation that GTPgS-
ter release and not spontaneous release. The resultsinduced depression was only partially occluded by the
suggest also that high frequency±induced synaptic de-PTX treatment. In PSCs, purinergic, adenosine, and pep-
pression may be glial in origin. Alternatively, PSCs maytidergic receptors are linked to PTX-sensitive G proteins,
not cause but rather modulate the presynaptic mecha-whereas muscarinic receptors are linked to PTX-insensi-
nisms causing the depression of transmitter release.tive G proteins (Robitaille, 1995; Robitaille et al., 1997;
The latter possibility appears more likely, since synapticBourque and Robitaille, 1998). Thus, the results suggest
depression occurs in immature nmjs in culture, condi-that muscarinic receptors may contribute to the glial
tions under which Schwann cells are absent (Dan andmodulation, since it is the only known type of PTX-
Poo, 1992).insensitive G protein±coupled receptor on PSCs. Adeno-
sine is also of particular interest, since it is known to
cause synaptic depression (Silinsky et al., 1989). Unfor- Glial Mechanisms of Transmitter
tunately, the identification of the endogenous neuro- Release Modulation
transmitters involved in activating PSCs and causing Glial cells, and Schwann cells in particular, are known
depression cannot be performed, since this would re- to release neuroactive substances (Bevan et al., 1973;
quire bath applications of agonists and antagonists, Dennis and Miledi, 1974; Martin, 1992; Parpura et al.,
which precludes definite conclusions because of the 1995). In addition, the release of neuroactive substances
unidentified sites of action of the drug (presynaptic, by glia has been shown to modulate neuronal activity
postsynaptic, or PSCs). For example, in addition to their in culture and in situ (Parpura et al., 1994; Pasti et al.,
location on PSCs (Robitaille, 1995), A1 adenosine recep- 1997). Hence, PSCs may release neuroactive substances
tors are also believed to be present on presynaptic nerve in response to the activation of G proteins elicited by
terminals (Silinsky et al., 1989). transmitter release. NO is a potential candidate for fulfill-
ing the role of glial messenger inducing synaptic depres-
sion, since it is known to reduce transmitter releaseSynaptic Depression: Induction
or Modulation by PSCs? (Lindgren and Laird, 1994) and since recent evidence
from our laboratory indicates that a neuronal type of NOPSCs do not modulate transmitter release on a tonic
basis as indicated by the lack of effect of G protein synthase is present in PSCs and not in the nerve terminal
of the frog nmj (Descarries and Robitaille, 1996, Soc.blockade with GDPbS. Consistent with this is the obser-
vation that PTX treatment does not affect transmitter Neurosci., abstract). This possibility is even more attrac-
tive in that the neuronal form of NO synthase is knownrelease per se (Silinsky et al., 1989; Robitaille et al.,
1997). Furthermore, the inefficacy of GDPbS on low rate to be Ca21-dependent, and a major consequence of
transmitter release activation of PSCs is an increase oftransmitter release indicates that the modulation by
PSCs was caused by the activation of large trimeric G intracellular Ca21 as a result of the release of Ca21 from
internal stores (Jahromi et al., 1992; Robitaille, 1995).proteins, since the injection of GDPbS should have had
the same effects as GTPgS if small G proteins were Another potential candidate could have been arachi-
donic acid and its derivatives, since Harish and Pooinvolved (Hess et al., 1993).
Synaptic depression induced by high frequency stim- (1992) showed that the injection of GTPgS in cultured
muscle fibers induced an increase in spontaneousulation was significantly reduced but not completely
abolished when GDPbS was present in PSCs preventing events and a reduction in EPC amplitude, mediated by
lipoxygenase metabolites. However, in adult, intact nmj,the activation of G proteins. Similarly, depression in-
duced by GTPgS occluded z75% of depression but derivatives of arachidonic acid strongly potentiate trans-
mitter release and increase quantal content rather thandid not block it completely. One possible interpretation
might be that G proteins in PSCs were only partially decreasing it (Madden and Van der Kloot, 1985; D. Pap-
pas and R. R., unpublished data). In addition, althoughblocked by GDPbS. This is unlikely as suggested by the
inability of agonists to elicit Ca21 responses. Indeed, the possible role of muscle fibers in the modulatory
process cannot be completely ruled out, the fact thatthere is evidence that the activation of receptors on
PSCs induces a large amplification of the initial signal, the injection of GTPgS in PSCs produced similar results
whether the electrical activity of the muscle fiber waswhereby the activation of a few receptors and/or G pro-
teins is believed to be sufficient to induce full scale Ca21 high (using m-conotoxin GIIIA) or low (using d-tubocura-
rine chloride) is a strong indication that muscle fibers,responses in PSCs (Robitaille et al., 1997). Hence, the
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intracellular electrode. The focal electrode recorded activity from aactivated by membrane depolarization, are not an es-
small portion of the nerve terminal branch (z20 mm). Finally, a PSCsential element in the production of the PSC modulation
covering the nerve terminal branch recorded by the focal electrodeof synaptic activity.
was penetrated by a microelectrode (35±55 MV, filled with 500 mM
Smith (1992) proposed that glia may regulate transmit- K-acetate). Thus, the focal electrode monitored the activity of the
ter release by controlling the level of extracellular Ca21 nerve terminal covered by the injected PSC. GTPgS and GDPbS
solutions of 10 mM in K-acetate (500 mM) were used for ionophoreticin the synaptic cleft. This is an attractive possibility,
injection (22 to 25 nA, 200 ms pulses every 2 s for 120 s). Also, asince the level of transmitter release is steeply related
fluorescent marker (Lucifer yellow or Ca21 green-1) was injectedto the Ca21 concentration. While appealing for a CNS
ionophoretically in the PSC to ascertain that the portion of the nervesynapse, owing to the restricted volume of the synaptic
terminal recorded by the focal electrode was covered by the injected
cleft tightly surrounded by glial processes, such a mech- PSC. Penetration of a PSC was deemed successful when the mem-
anism may not be practical for the nmj, since the synap- brane potential was 220 to 230 mV, when no sudden increase in
MEPP frequency (this occurred in z5% of the trials) or EPP ampli-tic cleft extends on a much larger area, and hence, glial
tude occurred, and when the injected fluorescent marker diffusedbuffering activity may not be as efficient.
quickly throughout the entire cell. Nmjs and PSCs were rejected if
any one of these criteria was not fulfilled. The nerve terminal under-
Glial Cells as Synaptic Partners neath PSCs could be seen, owing to its different diffraction proper-
It has been shown that PSCs are involved in the mainte- ties. Hence, it was possible to visually avoid touching the nerve
terminal when penetrating PSCs with the microelectrodes.nance of the nmj and growth cone guidance during syn-
Signals from the intracellular and focal electrodes were amplifiedapse regeneration (Son and Thompson, 1995a, 1995b;
10 times using an Axoclamp 2B and a Warner single channel ampli-Balice-Gordon, 1996; Trachtenberg and Thompson, 1996).
fier, respectively. Additional amplification (203 and 503, respec-In addition to this role, the present results reveal that
tively) was provided by a Warner amplifier and was filtered at 2 KHz
PSCs also modulate synaptic activity; that modulation with a four Bessel filter. The signal from the injection electrode was
is regulated by the level of synaptic activity itself. The monitored on the oscilloscope at a final gain of 1003. No filtering
of that signal was performed.actions of PSCs may be quite diverse, since the mecha-
nisms involved in the regulation of synapse formation
may be different from those involved in the modulation Ca21 Imaging of PSCs
PSCs injected with Ca21 green-1 were observed by using a 403of synaptic efficacy. Alternatively, it is possible that the
water immersion objective (Nikon 0.55 NA) on an Optiphot uprighttwo modulatory actions may be mediated by common
microscope. Ca21 responses in PSCs were evoked by repetitivefactors such as growth factors, since these molecules
stimulations of the motor nerve (50 Hz, 30 s). Adenosine (10 mm) or
may also be involved in the modulation of synaptic plas- Substance P (200 mM) were applied locally from a micropipette (5
ticity (Sasaki et al., 1995; Ruberti et al., 1997). mm tip diameter) on which a positive pressure (,20 psi, 999 ms)
In conclusion, the present observations indicate not was applied using a Picospritzer (General Valves). Images were
collected with an intensified CCD camera and were acquired withonly that perisynaptic glial cells detect and are modu-
Image 1 software (Universal Imaging; Robitaille, 1995; Robitaille etlated by synaptic activity (Jahromi et al., 1992; Reist
al., 1997). Images were collected at a rate of 2 images per second,and Smith, 1992; Georgiou et al., 1994; Robitaille, 1995;
and each image was an average of eight frames.
Bourque and Robitaille, 1998) but that they are actively
involved in the modulation and regulation of several
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